(Press-News.org) Hearing loss affects 36 million Americans to some degree, often leaving them feeling isolated, but it has received little attention from the pharmaceutical industry — until now. Small firms have brought a handful of potential therapies to the development pipeline, and pharmaceutical heavyweights are taking notice, according to an article in Chemical & Engineering News (C&EN), the weekly magazine of the American Chemical Society.
The story states that the most common cause of hearing loss is loud noise, either from a single event like the bang of a firecracker or from chronic exposure, say daily listening to a cranked-up iPod. Although severe hearing loss can be treated with a hearing aid or cochlear implants, options are scarce for those suffering from milder damage. But there is growing interest to fill the void and to even develop preventative treatments. Several drug candidates have already advanced through early clinical testing in patients.
Lisa M. Jarvis, a senior editor at C&EN, notes that potential treatments generally focus on two areas: the inner ear, where sound is first perceived, and the central nervous system (including the brain), where sound is processed. Researchers are using small molecules and gene therapy approaches to target different components, from re-growing the ear's hair cells to controlling how nerve cells involved in hearing work. Small companies firing up the field such as Audion Therapeutics have shown enough success that deeper-pocketed firms Eli Lilly & Co., Novartis and Roche are backing them up.
INFORMATION:
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 161,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter Facebook
Pharma firms turn attention to hearing loss
2014-04-09
ELSE PRESS RELEASES FROM THIS DATE:
Europeans and biomedical research
2014-04-09
This news release is available in French. The French National Institute of Health and Medical Research (Inserm) is currently the leading biomedical research organisation in Europe, and plays a key role in developing European research. To mark its 50th anniversary, Inserm wanted to assess the perceptions of Europeans regarding biomedical research.
To create this European panorama, Ipsos carried out an Internet survey of over 4,000 Europeans (with 1,001 French, 1,004 German, 1,001 Italians and 1,005 British respondents) from 10 to 23 January 2014. Representative samples ...
No compromises: JILA's short, flexible, reusable AFM probe
2014-04-09
JILA researchers have engineered a short, flexible, reusable probe for the atomic force microscope (AFM) that enables state-of-the-art precision and stability in picoscale force measurements. Shorter, softer and more agile than standard and recently enhanced AFM probes, the JILA tips will benefit nanotechnology and studies of folding and stretching in biomolecules such as proteins and DNA.
An AFM probe is a cantilever, shaped like a tiny diving board with a small, atomic-scale point on the free end. To measure forces at the molecular scale in a liquid, the probe attaches ...
Green is good
2014-04-09
As unlikely as it sounds, green tomatoes may hold the answer to bigger, stronger muscles.
Using a screening method that previously identified a compound in apple peel as a muscle-boosting agent, a team of University of Iowa scientists has now discovered that tomatidine, a compound from green tomatoes, is even more potent for building muscle and protecting against muscle atrophy.
Muscle atrophy, or wasting, is caused by aging and a variety of illnesses and injuries, including cancer, heart failure, and orthopedic injuries, to name a few. It makes people weak and fatigued, ...
The surgical treatment of bilateral benign nodular goiter
2014-04-09
About 100.000 thyroid operations are performed in Germany each year, a large percentage of them for the treatment of benign thyroid disease (euthyroid nodular goiter). In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2014; 111 (10): 161-8), Nada Rayes and colleagues suggest a paradigm shift in the treatment of such lesions. The article is accompanied by an editorial by Roland Gärtner.
Radical surgery has become much more common in the past few years and has been motivated by a desire to prevent recurrences. From 2006 to 2008, the percentage ...
One of the last strongholds for Western chimpanzees
2014-04-09
This news release is available in German. When Liberia enters the news it is usually in the context of civil war, economic crisis, poverty or a disease outbreak such as the recent emergence of Ebola in West Africa. Liberia's status as a biodiversity hotspot and the fact that it is home to some of the last viable and threatened wildlife populations in West Africa has received little media attention in the past. This is partly because the many years of violent conflict in Liberia, from 1989 to 1997 and from 2002 to 2003, thwarted efforts of biologists to conduct biological ...
The Lancet: Small cash incentives dramatically improve hepatitis B vaccination rates among injecting drug users
2014-04-09
Small financial incentives, totalling as little as £30, can dramatically increase the likelihood of people who inject drugs completing a course of hepatitis B virus (HBV) vaccination, according to new research published in The Lancet.
Researchers in the UK found that people undergoing treatment for heroin addiction who received a maximum total of £30 supermarket vouchers in equal or graduated instalments in return for full compliance with a regimen of three HBV vaccine injections were at least 12 times as likely to complete the course within 28 days compared to those ...
Processing new information during sleep compromises memory
2014-04-09
Washington, DC — New research appearing in the April 9 issue of the Journal of Neuroscience highlights the important role sleep plays in strengthening and maintaining the accuracy of a memory and hints at why the brain shuts out sensory information during periods of deep sleep. The study found that introducing new odor information to an animal while it sleeps compromises its ability to remember the difference between new and previously encountered smells while awake.
During sleep, the brain performs a number of important repair and maintenance duties that are necessary ...
Language structure ... you're born with it
2014-04-09
Humans are unique in their ability to acquire language. But how? A new study published in the Proceeding of the National Academy of Sciences shows that we are in fact born with the basic fundamental knowledge of language, thus shedding light on the age-old linguistic "nature vs. nurture" debate.
THE STUDY
While languages differ from each other in many ways, certain aspects appear to be shared across languages. These aspects might stem from linguistic principles that are active in all human brains. A natural question then arises: are infants born with knowledge of how ...
Lead continues to be a serious threat to California condor populations
2014-04-09
The California condor was one of the first species to be listed under the Endangered Species Preservation Act in 1966 when the population was reduced to a handful of birds. Through a massive collaborative effort that included fieldwork and breeding in zoos, the condor population has grown to more than 400 birds, more than half of which are now free-flying in the wild. Unfortunately, there is overwhelming evidence that lead poisoning from accidental ingestion of spent ammunition is the leading cause of death in the wild population, and this may prevent the establishment ...
Identified a new possible target to combat muscle wasting
2014-04-09
In the study published today in the Journal of Clinical Investigation (JCI), one of the journals with highest impact in experimental medicine, the researchers associate the activity of the DOR protein with muscle atrophy and point to DOR as a plausible target against which to develop a drug to prevent muscle deterioration in certain diseases.
DOR (Diabetes- and Obesity-regulated gene), also known as TP53INP2, is a protein involved in autophagy, a quality control process that ensures cells stay healthy. The researchers have found that increased DOR expression in the muscle ...